Multinationals Look To M&A As Key China Growth Driver
This article was originally published in PharmAsia News
Executive Summary
Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.